Effect of oral cromolyn sodium on CKD-associated pruritus and serum tryptase level: A double-blind placebo-controlled study

Nephrology Dialysis Transplantation

Volumn 25, Issue 5, 2010, Pages 1541-1547

  Vessal, Ghazal ^a   Sagheb, Mohammad Mehdi ^b   Shilian, Saman ^a   Jafari, Payman ^b   Samani, Soliman Mohammadi ^c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cromolyn sodium; Haemodialysis; Pruritus; Tryptase

Indexed keywords

CROMOGLYCATE DISODIUM; PLACEBO; TRYPTASE;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; ENZYME BLOOD LEVEL; FEMALE; FLATULENCE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MALE; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TREATMENT WITHDRAWAL;

ADMINISTRATION, ORAL; ADULT; AGED; CHRONIC DISEASE; CROMOLYN SODIUM; DOUBLE-BLIND METHOD; FEMALE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; PRURITUS; TRYPTASES;

EID: 77951676944     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp628     Document Type: Article

References (37)

1. Zucker I, Yosipovitch G, David M et al. Prevalence and characterization of uremic pruritus in patients undergoing hemodialysis: uremic pruritus is still a major problem for patients with end-stage renal disease. J Am Acad Dermatol 2003; 49: 842-846 (Pubitemid 37314871)
2. Pisoni RL, Wikstrom B, Elder SJ et al. Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2006; 21: 3495-3505 (Pubitemid 44817100)
3. Akhyani M, Ganji MR, Samadi N et al. Pruritus in hemodialysis patients. BMC Dermatol 2005; 5: 7 (Pubitemid 41554197)
4. Mettang T, Pauli-Magnus C, Alscher DM. Uraemic pruritus\new perspectives and insights from recent trials. Nephrol Dial Transplant 2002; 17: 1558-1563 (Pubitemid 35012156)
5. Yosipovitch G, Greaves MW, Schmelz M. Itch. Lancet 2003; 361: 690-694
6. Szczech LA, Lazar IL. Projecting the United States ESRD population: issues regarding treatment of patients with ESRD. Kidney Int Suppl 2004; 90: S3-S7
7. Carmichael AJ, McHugh MM, Martin AM et al. Serological markers of renal itch in patients receiving long term haemodialysis. Br Med J (Clin Res Ed) 1988; 296: 1575
8. Johansson O, Hilliges M, Stahle-Backdahl M. Intraepidermal neuron-specific enolase (NSE)-immunoreactive nerve fibres: evidence for sprouting in uremic patients on maintenance hemodialysis. Neurosci Lett 1989; 99: 281-286 (Pubitemid 19108767)
9. Berne B, Vahlquist A, Fischer T et al. UV treatment of uraemic pruritus reduces the vitamin A content of the skin. Eur J Clin Invest 1984; 14: 203-206 (Pubitemid 14110488)
10. Matsumoto M, Ichimaru K, Horie A. Pruritus and mast cell proliferation of the skin in end stage renal failure. Clin Nephrol 1985; 23: 285-288 (Pubitemid 15059838)
11. Dimkovic N, Djukanovic L, Radmilovic A et al. Uremic pruritus and skin mast cells. Nephron 1992; 61: 5-9
12. Rollino C, Goitre M, Piccoli G et al. What is the role of sensitiza-tion in uremic pruritus? An allergologic study. Nephron 1991; 57: 319-322
13. Hampers CL, Katz AI, Wilson RE et al. Disappearance of "uremic" itching after subtotal parathyroidectomy. N Engl J Med 1968; 279: 695-697
14. Narita I, Alchi B, Omori K et al. Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients. Kidney Int 2006; 69: 1626-1632
15. Francos GC, Kauh YC, Gittlen SD et al. Elevated plasma histamine in chronic uremia. Effects of ketotifen on pruritus. Int J Dermatol 1991; 30: 884-889
16. Stockenhuber F, Sunder-Plassmann G, Balcke P. Increased plasma histamine levels in chronic renal failure. NEngl J Med 1987; 317: 386 (Pubitemid 17118714)
17. Cho YL, Liu HN, Huang TP et al. Uremic pruritus: roles of parathyroid hormone and substance P. J Am Acad Dermatol 1997; 36: 538-543 (Pubitemid 27164484)
18. Szepietowski J, Thepen T, van Vloten WA et al. Pruritus and mast cell proliferation in the skin of haemodialysis patients. Inflamm Res 1995; 44 Suppl: S84-S85
19. Dugas-Breit S, Schopf P, Dugas M et al. Baseline serum levels of mast cell tryptase are raised in hemodialysis patients and associated with severity of pruritus. J Dtsch Dermatol Ges 2005; 3: 343-347 (Pubitemid 40754640)
20. Lugon JR. Uremic pruritus: a review. HemodialInt 2005; 9: 180-188
21. Mettang T, Fritz P, Weber J et al. Uremic pruritus in patients on hemodialysis or continuous ambulatory peritoneal dialysis (CAPD). The role of plasma histamine and skin mast cells. Clin Nephrol 1990; 34: 136-141 (Pubitemid 20295708)
22. Payne V, Kam PC. Mast cell tryptase: a review of its physiology and clinical significance. Anaesthesia 2004; 59: 695-703 (Pubitemid 38997011)
23. Berger A. PAR2 antagonists\the next generation of anti-inflamma-tories? BMJ 2000; 320: 334
24. Steinhoff M, Neisius U, Ikoma A et al. Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J Neurosci 2003; 23: 6176-6180 (Pubitemid 36875617)
25. Soter NA, Austen KF, Wasserman SI. Oral disodium cromoglycate in the treatment of systemic mastocytosis. N Engl J Med 1979; 301: 465-469 (Pubitemid 10219950)
26. Lindskov R, Lange Wantzin G, Knudsen L et al. Urticaria pigmento-sa treated with oral disodium cromoglycate. Dermatologica 1984; 169: 49-52 (Pubitemid 14083516)
27. Czarnetzki BM, Behrendt H. Urticaria pigmentosa: clinical picture and response to oral disodium cromoglycate. Br J Dermatol 1981; 105: 563-567 (Pubitemid 12231499)
28. Rosner MH. Cromolyn sodium: a potential therapy for uremic pruritus?. Hemodial Int 2006; 10: 189-192
29. Gunal AI, Ozalp G, Yoldas TK et al. Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial. Nephrol Dial Transplant 2004; 19: 3137-3139 (Pubitemid 40063517)
30. Rukwied R, Lischetzki G, McGlone F et al. Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients: a dermal microdialysis study. Br J Dermatol 2000; 142: 1114-1120 (Pubitemid 30418296)
31. Moeser AJ, Ryan KA, Nighot PK et al. Gastrointestinal dysfunction induced by early weaning is attenuated by delayed weaning and mast cell blockade in pigs. Am J Physiol Gastrointest Liver Physiol 2007; 293: G413-G421
32. Giovannetti S, Barsotti G, Cupisti A et al. Oral activated charcoal in patients with uremic pruritus. Nephron 1995; 70: 193-196 (Pubitemid 26013315)
33. Barnes PJ. Effect of nedocromil sodium on airway sensory nerves. J Allergy Clin Immunol 1993; 92: 182-186 (Pubitemid 23229861)
34. Jackson DM, Pollard CE, Roberts SM. The effect of nedocromil sodium on the isolated rabbit vagus nerve. Eur J Pharmacol 1992; 221: 175-177
35. Heinke S, Szucs G, Norris A et al. Inhibition of volume-activated chloride currents in endothelial cells by chromones. Br J Pharmacol 1995; 115: 1393-1398 (Pubitemid 26404078)
36. Javdan P, Figini M, Emanueli C et al. Nedocromil sodium reduces allergen-induced plasma extravasation in the guinea pig nasal mucosa by inhibition of tachykinin release. Allergy 1995; 50: 825-829
37. Crossman D, Dashwood M, Taylor G et al. Sodium cromoglycate\evidence of tachykinin antagonist activity in the human skin. J Appl Physiol 1993; 75: 167-172 (Pubitemid 23221971)